98%
921
2 minutes
20
Our previous studies identified a population of stem cell-like proliferating myeloid cells within inflamed tissues that could serve as a reservoir for tissue macrophages to adopt different activation states depending on the microenvironment. By lineage tracing cells derived from CX3CR1 precursors in mice during infection and profiling by scRNA-seq, here we identify a cluster of BIRC5 myeloid cells that expanded in the liver during either chronic infection with the parasite or the bacterial pathogen . In the absence of tissue damaging toxins, infection does not elicit these BIRC5 cells. Moreover, deletion of BIRC5 from CX3CR1 expressing cells results in improved survival during infection. Hence, the combination of scRNA-Seq and genetic fate mapping CX3CR1 cells revealed a toxin dependent pathogenic role for BIRC5 in myeloid cells during infection.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002671 | PMC |
http://dx.doi.org/10.1101/2023.02.27.529760 | DOI Listing |
Transl Oncol
August 2025
Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address:
Introduction: Extranodal NK/T-cell lymphoma (ENKTL) with cutaneous involvement can be divided into primary cutaneous ENKTL (pcENKTL) and secondary cutaneous involvement (scENKTL). Despite different originations, the clinical and histopathological findings are indistinguishable. Moreover, the prognosis determinants in each entity have yet to be established.
View Article and Find Full Text PDFBlood Neoplasia
December 2024
Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematopoietic neoplasm. Although the prognosis of pediatric T-ALL has improved with intensified chemotherapy regimens, this benefit has largely not translated to the adult T-ALL population. Development of new treatments requires understanding the mechanisms driven by specific mutations.
View Article and Find Full Text PDFmutations confer treatment resistance across multiple cancers. Mechanisms of therapy resistance, beyond affecting transactivation of BCL-2 family genes, remain a mystery. Here, we report that mutated AML, triple negative breast cancer, and colorectal cancer escape therapy-induced apoptosis due to inability to activate caspase-3/7, despite having normal mitochondrial outer membrane permeabilization (MOMP) induction.
View Article and Find Full Text PDFInt J Biol Macromol
June 2025
Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Abassia, 11566 Cairo, Egypt. Electronic address:
Hepatocellular carcinoma (HCC) is a complex malignancy driven by the dysregulation of multiple cellular pathways. Survivin, a key member of the inhibitor of apoptosis (IAP) family, plays a central role in HCC tumorigenesis and progression. Despite significant research, a comprehensive understanding of the contributions of survivin to the hallmarks of cancer, its molecular network, and its potential as a therapeutic target remains incomplete.
View Article and Find Full Text PDFACS Appl Mater Interfaces
January 2025
Epigenetics Research Laboratory, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India.
The heterogeneous form of malignancy in the myeloid lineage of normal hematopoietic stem cells (HSCs) is characterized as acute myeloid leukemia (AML). The t(9;11) reciprocal translocation (p22;q23) generates MLL-AF9 oncogene, which results in myeloid-based monoblastic AML with frequent relapse and poor survival. MLL-AF9 binds with the C-Myb promoter and regulates AML onset, maintenance, and survival.
View Article and Find Full Text PDF